Key trial findings Up to 16.3% weight loss at the 180 mg dose Results measured after around 11 months of treatment Low discontinuation rates (~23%) due to side effects Phase 3 trials planned later this year These results are particularly notable because oral GLP-1 drugs have historically struggled to match the effectiveness of injectable therapies
Esta restauracin favorece la alineacin circadiana, un equilibrio en la produccin endocrina y una funcin celular rejuvenecida, aportando un enfoque fisiolgico para modelos de declive hormonal asociado a la edad
Making Semaglutide Work: Practical Strategies Beyond the Injection Although semaglutide reduces hunger, intentional eating habits remain the foundation of sustained weight loss
Selenium supports thyroid function and may reduce thyroid antibody levels in Hashimoto patients
7 Further development of objective tools of assessment is warranted to evaluate the severity of graying and PHG more comprehensively
As lo anunci el pasado 24 de abril la agencia, organismo adscrito al Ministerio de Sanidad, en un comunicado en el que dijo esperar que este frmaco se comercialice en Espaa a partir de este mayo y en el que actualiza la situacin de los problemas de suministro de los medicamentos anlogos del GLP-1 y algunas de las recomendaciones para profesionales sanitarios
